Company Imv Inc Toronto S.E.
Equities
CA45254B1031
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hall
CEO | Chief Executive Officer | - | 20-11-09 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | - | - | |
Stéphane Fiset
CTO | Chief Tech/Sci/R&D Officer | - | - |
Annie Tanguay
CMP | Compliance Officer | - | - |
Jeremy Graff
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-13 |
Delphine Davan
IRC | Investor Relations Contact | - | 19-07-31 |
Linda Barabe
IRO | Public Communications Contact | - | - |
Ryan Marshall
PRN | Corporate Officer/Principal | - | 15-12-31 |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 20-06-30 | |
Kyle Kuvalanka
BRD | Director/Board Member | 56 | 21-03-31 |
Markus Warmuth
BRD | Director/Board Member | 53 | 18-11-05 |
Shabnam Kazmi
BRD | Director/Board Member | - | 23-01-07 |
Andrew Hall
CEO | Chief Executive Officer | - | 20-11-09 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
Michael Kalos
BRD | Director/Board Member | 62 | 21-05-10 |
Saman Maleki
BRD | Director/Board Member | - | 22-09-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,711,637 | 11,703,501 ( 99.93 %) | 0 | 99.93 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |